Your browser doesn't support javascript.
loading
Dual intracellular targeting by ruxolitinib and the Mcl-1 inhibitor S63845 in interleukin-6-dependent myeloma cells blocks in vivo tumor growth
Burger, Renate; Otte, Anna; Brdon, Jan; Peipp, Matthias; Gramatzki, Martin.
Afiliación
  • Burger R; Division of Stem Cell Transplantation and Immunotherapy, Department of Medicine II, University Medical Center Schleswig-Holstein and University of Kiel, Kiel. r.burger@med2.uni-kiel.de.
  • Otte A; Division of Stem Cell Transplantation and Immunotherapy, Department of Medicine II, University Medical Center Schleswig-Holstein and University of Kiel, Kiel.
  • Brdon J; Division of Stem Cell Transplantation and Immunotherapy, Department of Medicine II, University Medical Center Schleswig-Holstein and University of Kiel, Kiel.
  • Peipp M; Division of Stem Cell Transplantation and Immunotherapy, Department of Medicine II, University Medical Center Schleswig-Holstein and University of Kiel, Kiel.
  • Gramatzki M; Division of Stem Cell Transplantation and Immunotherapy, Department of Medicine II, University Medical Center Schleswig-Holstein and University of Kiel, Kiel.
Haematologica ; 106(9): 2507-2510, 2021 Sep 01.
Article en En | MEDLINE | ID: mdl-33882638
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interleucina-6 / Mieloma Múltiple Límite: Humans Idioma: En Revista: Haematologica Año: 2021 Tipo del documento: Article Pais de publicación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interleucina-6 / Mieloma Múltiple Límite: Humans Idioma: En Revista: Haematologica Año: 2021 Tipo del documento: Article Pais de publicación: Italia